Senate Hearing on Chemical Regulations: PFAS, Innovation, and Public Health

Chemical Regulation and Innovation

• 💡 The Senate Environment Subcommittee convened a hearing on regulating new and existing chemicals, focusing on the balance between innovation, safety, and US competitiveness.
• 🎯 Witnesses from Huntsman Corporation and Boeing highlighted the critical relationship between chemical manufacturers and downstream users, emphasizing how chemical innovation drives advancements in various industries.
• 🔑 A key concern is that regulatory delays and ambiguities in the chemical approval process can stifle innovation, potentially leading companies to move research overseas.

TCSA and Regulatory Challenges

• ⚖️ The Toxic Substance Control Act (TUSCa) was amended in 2016 to improve the EPA's ability to evaluate and regulate chemicals, aiming for stronger protections for vulnerable populations.
• ⚠️ Concerns were raised about industry influence and lobbying potentially undermining scientific rigor and weakening regulatory standards at the EPA.
• ⏳ The EPA's review process for new chemicals frequently exceeds statutory timelines, creating uncertainty for manufacturers and users like Boeing, which has long product development cycles.

Health Impacts of Chemicals

• 🔬 Dr. Tracy Woodruff presented research on the health risks associated with widespread chemical exposures, including microplastics, PFAS, and additives in plastics, linking them to reproductive issues, cancers, and developmental problems.
• ⚠️ The persistence of PFAS chemicals was highlighted, with calls for addressing the entire class of chemicals rather than individual compounds due to their widespread presence and potential health impacts.
• 🏭 Industry knowledge of chemical harms, such as with PFAS, dating back decades before public awareness, was cited as an example of the need for transparency and unbiased science.

Global Competitiveness and Policy

• 🚀 Delays in US chemical approvals can lead to a strategic disadvantage, with countries like China investing heavily and approving new chemistries faster, potentially shifting innovation and manufacturing abroad.
• 🌍 The need for a predictable, science-based, and efficient regulatory system was stressed to maintain US leadership in advanced manufacturing and chemical innovation.
• 🤝 A call was made for bipartisan agreement to address issues like PFAS in drinking water and to ensure that regulatory frameworks keep pace with scientific advancements and industry innovation.